Dr. Reddy's Laboratories Limited (RDY)

Dr. Reddy's Laboratories Income Statement

Financials in millions INR. Fiscal year is April - March.

Year	2023	2022	2021	2020	2019
Revenue	279,164	245,879	214,391	189,722	174,600
Revenue Growth (YoY)	13.54%	14.69%	13.00%	8.66%	13.49%
Cost of Revenue	115,557	106,536	100,551	86,645	80,591
Gross Profit	163,607	139,343	113,840	103,077	94,009
Selling, General & Admin	77,201	68,026	62,081	54,650	50,129
Research & Development	22,873	19,381	17,482	16,541	15,410
Other Operating Expenses	-4,196	-5,208	4,801	7,606	12,477
Operating Expenses	95,878	82,199	84,364	78,797	78,016
Operating Income	67,729	57,144	29,476	24,280	15,993
Interest Expense / Income	1,711	1,428	958	970	983
Other Expense / Income	-5,852	-4,651	-3,780	-3,103	-3,022
Pretax Income	71,870	60,367	32,298	26,413	18,032
Income Tax	16,186	15,300	8,730	9,175	-1,466
Net Income	55,684	45,067	23,568	17,238	19,498
Net Income Growth	23.56%	91.22%	36.72%	-11.59%	3.74%
Shares Outstanding (Basic)	167	166	166	166	166
Shares Change	0.06%	0.07%	0.08%	0.06%	0.09%
EPS (Basic)	334.65	271.43	142.08	103.94	117.63
EPS (Diluted)	334.02	270.85	141.69	103.65	117.40
EPS Growth	23.32%	91.16%	36.70%	-11.71%	3.81%
Free Cash Flow	19,062	40,091	9,429	26,047	25,126
Free Cash Flow Per Share	114.47	240.89	56.70	156.75	151.30
Dividend Per Share	0.975	0.774	0.684	0.330	0.267
Dividend Growth	25.97%	13.16%	107.27%	23.60%	-8.56%
Gross Margin	58.61%	56.67%	53.10%	54.33%	53.84%
Operating Margin	24.26%	23.24%	13.75%	12.80%	9.16%
Profit Margin	19.95%	18.33%	10.99%	9.09%	11.17%
Free Cash Flow Margin	6.83%	16.31%	4.40%	13.73%	14.39%
Effective Tax Rate	22.52%	25.34%	27.03%	34.74%	-8.13%
EBITDA	88,422	74,431	45,080	40,179	31,487
EBITDA Margin	31.67%	30.27%	21.03%	21.18%	18.03%
Depreciation & Amortization	14,841	12,636	11,824	12,796	12,472
EBIT	73,581	61,795	33,256	27,383	19,015
EBIT Margin	26.36%	25.13%	15.51%	14.43%	10.89%

Source: Financials are provided by Nasdaq Data Link and sourced from audited reports submitted to the Securities and Exchange Commission (SEC).